C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/06 (2006.01) A61K 31/519 (2006.01) A61K 31/522 (2006.01) A61P 11/06 (2006.01) C07D 473/08 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2536553
The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
La présente invention concerne des composés et des compositions pharmaceutiques, qui sont des antagonistes sélectifs des récepteurs de l'adénosine A¿2B? (AR). Les composés et compositions de l'invention sont utiles comme substances pharmaceutiques.
Rieger Jayson M.
Thompson Robert D.
Wang Guoquan
Adenosine Therapeutics Llc
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Trovis Pharmaceuticals Llc
LandOfFree
Substituted 8-heteroaryl xanthines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 8-heteroaryl xanthines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 8-heteroaryl xanthines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1910457